Amalgamated Bank’s Imago BioSciences IMGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-3,856
Closed -$139K – 2980
2022
Q4
$139K Hold
3,856
– – ﹤0.01% 1995
2022
Q3
$58K Buy
3,856
+37
+1% +$600 ﹤0.01% 2400
2022
Q2
$51K Buy
3,819
+1,674
+78% +$26.6K ﹤0.01% 2480
2022
Q1
$41K Buy
+2,145
New +$44.5K ﹤0.01% 2570

Amalgamated Bank's IMGO Position: Q1 2023 in Review

Amalgamated Bank sold out of Imago BioSciences (IMGO) in Q1 2023, closing a stake of 3,856 shares — an estimated $139K sold.

Amalgamated Bank first reported a position in IMGO in Q1 2022 and held it in 4 quarters. The position peaked at $139K in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Amalgamated Bank reported no remaining Imago BioSciences position as of Q1 2023 after selling out during the quarter.
  • Amalgamated Bank sold 3,856 Imago BioSciences shares in Q1 2023, an estimated $139K.
  • Amalgamated Bank first reported a position in Imago BioSciences in Q1 2022 and held it in 4 quarters.
  • Amalgamated Bank's Imago BioSciences position peaked at $139K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences as of Q1 2023.

Based on Amalgamated Bank's 13F filing for Q1 2023, filed 2 May 2023.